Showing results (21-30 of 1,128) with videos related to
Sort By:
Pageof 113
Journal of Hepatocellular Carcinoma|February 20, 2025
Effect of Narrow-Margin Hepatectomy Combined with Intraoperative Radiotherapy on Long-Term Prognosis of Patients with Centrally Located Hepatocellular Carcinoma: A Propensity Score Matching AnalysisChangcheng Tao, Liguo Liu, Nan Hu, et al.Journal of Hepatocellular Carcinoma|November 6, 2024
Predicting Pathological Response of Neoadjuvant Conversion Therapy for Hepatocellular Carcinoma Patients Using CT-Based Radiomics ModelHaoxiang Wen, Ruiming Liang, Xiaofei Liu, et al.Journal of Hepatocellular Carcinoma|November 4, 2024
FOLFOX-Based Hepatic Arterial Infusion Chemotherapy with Sequential Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Large Hepatocellular Carcinoma: A Single-Center Retrospective Cohort StudyRongce Zhao, Jing Zhou, Zehao Zheng, et al.Journal of Hepatocellular Carcinoma|October 28, 2024
Prognosis of Patients with Hepatocellular Carcinoma Treated with TACE: A New Score Combining Alpha-Fetoprotein and Des-γ-Carboxy ProthrombinShang-Yu Lu, Han-Yao Sun, Yan Zhou, et al.Journal of Hepatocellular Carcinoma|October 28, 2024
Transarterial Chemoembolization Combined with Microwave Ablation in Elderly Patients with Recurrent Medium or Large Hepatocellular CarcinomaChuxiao Zhang, Yuelan Qin, Yangguang Song, et al.Journal of Hepatocellular Carcinoma|November 7, 2025
Predictive Value of Hepatic Steatosis for Postoperative Recurrence in Hepatitis B-Related Hepatocellular Carcinoma: Development of a Machine Learning-Based Prognostic ModelAoyun Hao, Changlei Li, Ruitao Sun, et al.Journal of Hepatocellular Carcinoma|November 6, 2025
The Role of Nuclear Medicine in Predicting Treatment Response to Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma: A Narrative ReviewHaibin Tu, Dingluan Lin, Cailong ChenJournal of Hepatocellular Carcinoma|October 8, 2025
Early PIVKA-II Response Associated with Treatment Efficacy and Survival Outcomes for Patients with Advanced Hepatocellular Carcinoma Receiving Immune Checkpoint Inhibitors and Targeted TherapyZheng-Kang Fang, Yu-Ting Xiao, Xia Feng, et al.Journal of Hepatocellular Carcinoma|October 6, 2025
Adjuvant TACE Improves Prognosis After Resection in Dual-Phenotype Hepatocellular Carcinoma: A Propensity Score-Matched StudyZijian Leng, Taifeng Zhu, Ziyue Huang, et al.Journal of Hepatocellular Carcinoma|October 15, 2025
Prognostic Value of Clinical and CT Features in Camrelizumab Plus Apatinib Treatment for Unresectable Hepatocellular CarcinomaJinlian Che, Yidi Chen, Zhiming Zeng, et al.Pageof 113